7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 
      
                          
      operating expenses:
                          
      research and development
    209,933,000 194,179,000 148,134,000 133,614,000 116,936,000 131,507,000 94,587,000 104,150,000 97,421,000 72,691,000 58,080,000 51,626,000 47,679,000   23,074,000 20,428,000 17,651,000 17,258,000 14,661,000 16,410,000 18,178,000 
      general and administrative
    32,447,000 32,040,000 32,659,000 28,555,000 22,988,000 21,474,000 19,885,000 17,526,000 15,605,000 14,456,000 13,112,000 11,952,000 10,898,000 9,417,000 7,543,000 6,772,000 6,523,000 6,079,000 5,885,000 4,792,000 4,898,000 3,046,000 
      total operating expenses
    242,380,000 226,219,000 180,793,000 162,169,000 139,924,000 152,981,000 114,472,000 196,676,000 113,026,000 87,147,000 71,192,000 86,573,000 58,577,000 47,886,000 39,221,000 29,846,000 26,951,000 23,730,000 23,143,000 19,453,000 21,308,000 21,224,000 
      income from operations
    -242,380,000 -226,219,000 -180,793,000 -162,169,000 -139,924,000 -152,981,000 -114,472,000 -196,676,000 -113,026,000 -87,147,000 -71,192,000 -86,573,000 -58,577,000 -47,886,000 -39,221,000 -29,846,000 -26,951,000 -23,730,000 -23,143,000 -19,453,000 -21,308,000 -21,224,000 
      yoy
    73.22% 47.87% 57.94% -17.55% 23.80% 75.54% 60.79% 127.18% 92.95% 81.99% 81.52% 190.07% 117.35% 101.80% 69.47% 53.43% 26.48% 11.81%     
      qoq
    7.14% 25.13% 11.48% 15.90% -8.54% 33.64% -41.80% 74.01% 29.70% 22.41% -17.77% 47.79% 22.33% 22.09% 31.41% 10.74% 13.57% 2.54% 18.97% -8.71% 0.40%  
      operating margin %
                          
      other income, net:
                          
      interest income
    29,259,000 31,073,000 32,935,000 36,458,000 28,057,000 23,813,000 21,666,000 17,568,000 18,495,000 16,451,000 10,393,000 6,633,000 1,190,000 399,000 134,000 99,000 90,000 93,000 61,000 32,000 33,000 44,000 
      other income
    291,000 28,573,000 7,140,000                    
      total other income
    29,550,000 59,646,000 40,075,000 25,089,000 36,800,000 24,278,000 19,452,000 15,875,000 20,362,000 18,808,000 10,730,000 8,523,000 660,000 -646,000 235,000 1,283,000 336,000 51,000 1,923,000 -1,284,000 290,000 904,000 
      net income
    -212,830,000 -166,573,000 -140,718,000 -137,080,000 -103,124,000 -128,703,000 -95,020,000 -180,801,000 -92,664,000 -68,339,000 -60,462,000 -78,050,000 -57,917,000 -48,532,000 -38,986,000 -28,563,000 -26,615,000 -23,679,000 -21,220,000    
      yoy
    106.38% 29.42% 48.09% -24.18% 11.29% 88.33% 57.16% 131.65% 59.99% 40.81% 55.09% 173.26% 117.61% 104.96% 83.72%        
      qoq
    27.77% 18.37% 2.65% 32.93% -19.87% 35.45% -47.44% 95.11% 35.59% 13.03% -22.53% 34.76% 19.34% 24.49% 36.49% 7.32% 12.40% 11.59%     
      net income margin %
                          
      net income per share
    -1.56 -1.22 -1.04 -1.02 -0.83 -1.1 -0.85 -1.82 -0.91 -0.7 -0.7 -1.02 -0.93 -0.8 -0.68 -0.54 -0.51 -0.46 -0.41 0.04 -0.41 -1.72 
      weighted-average shares outstanding, basic and diluted
    136,196,512 136,033,746 135,690,949 121,997,348 123,693,461 117,256,561 111,690,951 97,157,690 101,668,655 98,057,870 86,206,817 64,877,988 61,989,347 60,818,778 57,547,808 51,922,108 52,187,303 51,508,340 51,174,978 29,545,810 50,895,358 11,803,778 
      grant income
       203,000 292,000 394,000 126,000 6,000 1,640,000 2,464,000 654,000 925,000 157,000 690,000 160,000 908,000 299,000 378,000  326,000 787,000 1,036,000 
      realized gains on marketable securities
       12,500 1,000 27,000 22,000                
      foreign currency transaction gains
       1,533,000 8,450,000 44,000  -1,699,000 227,000  -317,000 1,009,000 -687,000 -1,733,000 6,000 276,000 -54,000 -414,000 1,862,000    
      foreign currency transaction losses
          -2,362,000   -107,000          -1,642,000 -530,000 -176,000 
      interest expense
                 -2,000    -7,000     
      realized losses on marketable securities
                          
      realized gain on marketable securities
                   500 1,000 1,000     
      research and development (including related party expenses of 0 and 747 for the three months ended june 30, 2022 and 2021, respectively, and 0 and 2,359 for the six months ended june 30, 2022 and 2021, respectively
                 38,469,000         
      research and development (including related party expenses of 0 and 1,612 for the three months ended march 31, 2022 and 2021, respectively
                  31,678,000        
      realized loss on marketable securities
                  -65,000        
      change in fair value of the redeemable convertible preferred stock tranche liability
                          
      net income and comprehensive loss
                       -20,737,000 -21,018,000 -20,320,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.